Dr. Robert Tabrizi, MD

Dr. Tabrizi practices at Expedite Urgent Care in Apple Valley, California.

Dr. Tabrizi's NPI, 1417233735, was assigned on November 1, 2011. Dr. Tabrizi graduated from St. George's University School of Medicine in 2009. Dr. Tabrizi's New York license number on file is 298860.

Dr. Tabrizi's primary practice is Expedite Urgent Care, at 18564 Us-18, Apple Valley, CA 92307 in San Bernardino County. The practice phone is (559) 721-4110.

Dr. Tabrizi's primary practice is Expedite Urgent Care in Apple Valley, California. Dr. Tabrizi is also affiliated with Dignity Health - Mercy Medical Center. The medical group on file is Expedite Urgent Care. Dmand AI also links Dr. Tabrizi to 2 more hospitals, 5 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabrizi practices, 9 sites in all. Vendor and product names are available with a free account.

Adult medicine is Dr. Tabrizi's primary specialty in the NPI Registry, under taxonomy code 207QA0505X. Dr. Tabrizi is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Tabrizi's licenses on file in 2 states: New York and California.

Dmand AI lists acid reflux, acute skin infection, adjustment disease, alcohol use disorders, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Tabrizi treats.

CMS data shows 1,831 Medicare services from Dr. Tabrizi across 14 procedure codes in 2024, for 359 Medicare patients. Medicare paid $129,060 for them. Every service was in an office.

CMS counts 359 Medicare patients who saw Dr. Tabrizi in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tabrizi's median patient age at 34, with 61% women.

In 2024, Dr. Tabrizi wrote 4,447 Medicare Part D claims for 452 patients. 81% of them were for generic drugs. CMS names the drug for 3,798 of them, across 88 drugs with 11 or more claims each, at $606,766 in total drug cost. In 2023, CMS named 4,860 claims across 102 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tabrizi for performance year 2024, reported through an alternative payment model (APM). Dr. Tabrizi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabrizi as offering telehealth.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 31 general payments to Dr. Tabrizi from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Eli Lilly and Company paid the most, $227.

Dr. Tabrizi graduated from St. George's University School of Medicine in 2009.

Dr. Tabrizi is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.